Gastro-Mint
View our Gastro-Mint® product for the relief of symptoms of medically diagnosed Irritable Bowel Syndrome.
Join our team
We’re always looking for talented people, please have a look at the careers we currently have available.
Latest news
Keep up to date with the latest news from AFT Pharmaceuticals
July 23, 2026
Pitt St Research initiates coverage on AFT Pharmaceuticals
AFT Pharmaceuticals (NZX: AFT; ASX: AFP), today announces that Pitt St Research has initiated coverage on AFT Pharmaceuticals Ltd….
November 20, 2025
AFT delivers 10th consecutive first half revenue increase
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…
September 25, 2025
On track for $300m FY27 revenue; positive iron IV study result
– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …